about
Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided ApproachesPreparation of mineralized nanofibers: collagen fibrils containing calcium phosphate.Magneto-fluorescent core-shell supernanoparticles.Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicityICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast CancerInhibiting metastatic breast cancer cell migration via the synergy of targeted, pH-triggered siRNA delivery and chemokine axis blockadeMapping the CXCR4 receptor on breast cancer cells.A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release.pH-responsive scaffolds generate a pro-healing response.Fabrication of biodegradable nano test tubes by template synthesis.Microfluidic capture and release of bacteria in a conical nanopore array.General method for producing organic nanoparticles using nanoporous membranes.A quantitative method for screening and identifying molecular targets for nanomedicine.Characterization of dormant and active human cancer cells by quantitative phase imaging.An efficient bicomponent TiO2/SnO2 nanofiber photocatalyst fabricated by electrospinning with a side-by-side dual spinneret method.One-step fabrication and high photocatalytic activity of porous TiO2 hollow aggregates by using a low-temperature hydrothermal method without templates.Using Atomic Force Microscopy to Predict Tumor Specificity of ICAM1 Antibody-Directed Nanomedicines.Preparing amorphous hydrophobic drug nanoparticles by nanoporous membrane extrusionBiomimetic alginate/polyacrylamide porous scaffold supports human mesenchymal stem cell proliferation and chondrogenesisNanomaterial Preparation by Extrusion through Nanoporous Membranes
P50
Q30354223-4B87AB68-C53B-4FA3-BC89-64F53359B608Q34647903-3F088464-53D0-41E6-8113-399D86AE9C9DQ34688773-80335660-9533-423A-A930-0A76AC5AEFABQ36332186-8E692B1F-D8DF-4C10-9D97-94A2488DD838Q36372319-F4B2C312-BCEB-42C6-82D6-B002F92CA188Q37714248-0899E5B1-350E-41F4-B24D-B2785FFB2881Q38881883-A822058B-A665-46A1-94BC-C98A65B3A534Q39180899-A273AE00-F50F-404F-8D31-C832BC510459Q42827476-D54F3F7C-5CCC-43C4-BB2D-550AE37D5520Q42840541-DEC1CB65-DFC8-4D58-8084-EF86383AD8EFQ46168271-340E9F25-B9CA-414D-B168-1948DEB4B949Q46357108-99EF97A3-5579-4718-A71F-54E232F66E3CQ47315180-207654C7-5B67-4E0F-A811-1F5E4F1EC967Q48681495-DB101E31-E300-43F4-9C18-4ED3141A1B75Q51027806-08E4658E-8075-4120-95CC-488FE7067FB8Q51099809-FE1BC9ED-D7EF-45BB-BB2C-5F706901D527Q52674093-75CA1C3C-5763-4CC7-B40D-BE8D4A4059A6Q84922871-53525E90-0E28-4292-AA0B-7D97BDE7D420Q87446707-5A5F586F-5101-4E88-85CE-FA9DADA8AEFFQ87845574-1E7A7EED-4392-4C54-8B10-59E2A2B57405
P50
description
researcher
@en
հետազոտող
@hy
name
Peng Guo
@ast
Peng Guo
@en
Peng Guo
@es
Peng Guo
@nl
Peng Guo
@sl
type
label
Peng Guo
@ast
Peng Guo
@en
Peng Guo
@es
Peng Guo
@nl
Peng Guo
@sl
prefLabel
Peng Guo
@ast
Peng Guo
@en
Peng Guo
@es
Peng Guo
@nl
Peng Guo
@sl
P1053
L-1689-2013
P106
P31
P496
0000-0003-1689-5622